JPH03112491A - Production of l-homophenylalanine - Google Patents
Production of l-homophenylalanineInfo
- Publication number
- JPH03112491A JPH03112491A JP24883789A JP24883789A JPH03112491A JP H03112491 A JPH03112491 A JP H03112491A JP 24883789 A JP24883789 A JP 24883789A JP 24883789 A JP24883789 A JP 24883789A JP H03112491 A JPH03112491 A JP H03112491A
- Authority
- JP
- Japan
- Prior art keywords
- homophenylalanine
- genus
- acid
- lactic acid
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- JTTHKOPSMAVJFE-VIFPVBQESA-N L-homophenylalanine Chemical compound OC(=O)[C@@H](N)CCC1=CC=CC=C1 JTTHKOPSMAVJFE-VIFPVBQESA-N 0.000 title claims abstract description 36
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 238000006243 chemical reaction Methods 0.000 claims abstract description 22
- IBIBMVNOBCIJNU-UHFFFAOYSA-N 2-hydroxy-2-methyl-3-phenylpropanoic acid Chemical compound OC(=O)C(O)(C)CC1=CC=CC=C1 IBIBMVNOBCIJNU-UHFFFAOYSA-N 0.000 claims abstract description 12
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 4
- 241000186146 Brevibacterium Species 0.000 claims abstract description 4
- 241000186216 Corynebacterium Species 0.000 claims abstract description 3
- 241001467578 Microbacterium Species 0.000 claims abstract description 3
- 241000186063 Arthrobacter Species 0.000 claims abstract 2
- 230000001580 bacterial effect Effects 0.000 claims description 18
- 244000005700 microbiome Species 0.000 claims description 12
- 230000003287 optical effect Effects 0.000 abstract description 10
- 239000000758 substrate Substances 0.000 abstract description 9
- 239000000203 mixture Substances 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 abstract description 3
- 241001485655 Corynebacterium glutamicum ATCC 13032 Species 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 239000005541 ACE inhibitor Substances 0.000 abstract description 2
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 abstract description 2
- 239000002243 precursor Substances 0.000 abstract description 2
- 241000588923 Citrobacter Species 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 17
- 239000002609 medium Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 238000012258 culturing Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000186226 Corynebacterium glutamicum Species 0.000 description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 241001517047 Corynebacterium acetoacidophilum Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 2
- JTTHKOPSMAVJFE-UHFFFAOYSA-N 2-azaniumyl-4-phenylbutanoate Chemical compound OC(=O)C(N)CCC1=CC=CC=C1 JTTHKOPSMAVJFE-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000970818 Cyclobacterium Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- -1 ammonium fumarate Chemical class 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229960002510 mandelic acid Drugs 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- IWYDHOAUDWTVEP-SSDOTTSWSA-N (R)-mandelic acid Chemical compound OC(=O)[C@H](O)C1=CC=CC=C1 IWYDHOAUDWTVEP-SSDOTTSWSA-N 0.000 description 1
- ORLFVWPPBMVPNZ-UHFFFAOYSA-N 1-(6-methylheptyl)-4-[4-(6-methylheptyl)phenoxy]benzene Chemical compound C1=CC(CCCCCC(C)C)=CC=C1OC1=CC=C(CCCCCC(C)C)C=C1 ORLFVWPPBMVPNZ-UHFFFAOYSA-N 0.000 description 1
- JTWUZULPZAALRN-UHFFFAOYSA-N 3-hydroxy-5-(hydroxymethyl)-2-methylpyridine-4-carbaldehyde;phosphoric acid Chemical compound OP(O)(O)=O.CC1=NC=C(CO)C(C=O)=C1O JTWUZULPZAALRN-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000001729 Ammonium fumarate Substances 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- 241000807905 Corynebacterium glutamicum ATCC 14067 Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241000319304 [Brevibacterium] flavum Species 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001514 alkali metal chloride Inorganic materials 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000019297 ammonium fumarate Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- CKKXWJDFFQPBQL-SEPHDYHBSA-N azane;(e)-but-2-enedioic acid Chemical compound N.N.OC(=O)\C=C\C(O)=O CKKXWJDFFQPBQL-SEPHDYHBSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- ZPIRTVJRHUMMOI-UHFFFAOYSA-N octoxybenzene Chemical compound CCCCCCCCOC1=CC=CC=C1 ZPIRTVJRHUMMOI-UHFFFAOYSA-N 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- 229960001327 pyridoxal phosphate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〈産業上の利用分野〉
本発明は、L−ホモフェニルアラニンの製造方法の関す
る。L−ホモフェニルアラニンは、たとえばACEイン
ヒビターの前駆体として、有用な下記式(A)
で示される化合物の原料として極めて有用である。DETAILED DESCRIPTION OF THE INVENTION <Industrial Application Field> The present invention relates to a method for producing L-homophenylalanine. L-homophenylalanine is extremely useful as a raw material for a compound represented by the following formula (A), which is useful, for example, as a precursor of an ACE inhibitor.
〈従来の技術〉
従来、L−ホモフェニルアラニンの製造方法としては、
光学活性なマンデル酸とDL−ホモフェニルアラニンか
らDL−ホモフェニルアラニン・光学活性マンデル酸複
合体を光学分割し、析出したL−ホモフェニルアラニン
・D (−)−マンデル酸複合体からL−ホモフェニル
アラニンを採取する方法(特開昭63−145256号
公報)およびアシラーゼを用いたN−アセチル−DL−
ホモフェニルアラニンの不斉加水分解法(l1cm、
Fac、 Set、、 Kyssb* Uni、、 S
er、仁13.89 <1981))などが知られてい
る。<Conventional technology> Conventionally, as a method for producing L-homophenylalanine,
DL-homophenylalanine/optically active mandelic acid complex is optically resolved from optically active mandelic acid and DL-homophenylalanine, and L-homophenylalanine is collected from the precipitated L-homophenylalanine/D(-)-mandelic acid complex. N-acetyl-DL- using a method of
Asymmetric hydrolysis method of homophenylalanine (l1cm,
Fac, Set,, Kyssb* Uni,, S
er, Jin 13.89 <1981)) are known.
〈発明が解決しようとする課題〉
しかし、酵素を用いるL−ホモフェニルアラニンの製造
では、反応基質の濃度が0.4〜0.5%と低いことに
難点があり、また、光学分割剤を用いた分割法では分割
剤が天然物で高価であること、さらに光学純度の高いL
−ホモフェニルアラニンが高収率で得られないことに難
点がある。<Problem to be solved by the invention> However, the production of L-homophenylalanine using an enzyme has the disadvantage that the concentration of the reaction substrate is as low as 0.4 to 0.5%, and it is difficult to use an optical resolution agent. In the conventional separation method, the resolving agent is a natural product and is expensive, and in addition, L with high optical purity is used.
-The drawback is that homophenylalanine cannot be obtained in high yield.
本発明の目的は、光学純度の高いL−ホモフェニルアラ
ニンを効率よくかつ安価に製造する方法を提供すること
にある。An object of the present invention is to provide a method for efficiently and inexpensively producing L-homophenylalanine with high optical purity.
く課題を解決するための手段〉 上記目的は、以下の本発明により達成される。Means to solve problems〉 The above object is achieved by the present invention as described below.
すなわち、本発明は、ベンジル乳酸をL−ホモフェニル
アラニンに変換する能力を有しかつコリネバクテリウム
(Cory++ebacteriwml属、ブレビバク
テリウム(Brevibacterlaml属、バシラ
ス(Bacil1msl属、ミクロバクテリウム(璽i
crobacteriuml属またはアースロバフタ−
(Artkrobacterl属に属する微生物より選
ばれた少なくとも1種の微生物の培養物、菌体またはそ
の処理物をベンジル乳酸に作用させてL−ホモフェニル
アラニンを生成蓄積せしめ、反応液からL−ホモフェニ
ルアラニンを単離採取することを特徴とするL−ホモフ
ェニルアラニンの製法である。That is, the present invention has the ability to convert benzyl lactic acid to L-homophenylalanine, and is capable of converting benzyl lactic acid into L-homophenylalanine.
Crobacterium genus or Arthrobacterium
(L-homophenylalanine is produced and accumulated by acting on benzyl lactic acid with a culture, bacterial cells, or a processed product thereof of at least one microorganism selected from the microorganisms belonging to the genus Artkrobacterl, and L-homophenylalanine is isolated from the reaction solution. This is a method for producing L-homophenylalanine, which is characterized by separate collection.
以下、本発明の構成を詳細に説明する。Hereinafter, the configuration of the present invention will be explained in detail.
本発明で原料として使用するベンジル乳酸は8体、ラセ
ミ体のいずれでもよい0通常は工業的に有利なラセミ体
を用いる。The benzyl lactic acid used as a raw material in the present invention may be either a racemic form or a racemic form, which is usually an industrially advantageous racemic form.
本発明においてはベンジル乳酸をL−ホモフェニルアラ
ニンに変換する能力を有しかつコリネバクテリウム(C
ory++ebacterium)属、ブレビバクテリ
ウム[BrevibacteriumlJ[、バシラス
(Bacillusl属、ミクロバクテリウム(Mic
robactcr1w+al属またはアースロバフタ−
(Artbrobactcrl属に属する微生物より選
ばれた少なくとも1種の微生物を用いる。In the present invention, Corynebacterium (C
ory++ebacterium), Brevibacterium [BrevibacteriumJ[, Bacillus genus, Microbacterium (Mic
robactcr1w+al or Arthrobacterium
(At least one type of microorganism selected from microorganisms belonging to the genus Artbrobactcrl is used.
かかる微生物であればいずれでも使用できる。Any such microorganism can be used.
たとえば、その代表的なものを例示すれば、コリネバク
テリウムリウム・グルタミカムATCC13032、コ
リネバクテリウム・グルタミカムATCC21651、
コリネバクテリウム・アセトアシドフィルムATC01
3870、コリネバクテリウム・アセトアシドフィルム
ATCC21270、ブレビバクテリウム・ラクトファ
ーメンタムATCC13869、ブレビバクテリウム・
フラブムATCC14067、ブレビバクテリウム・フ
ラブムATCC13826、アースロバフタ−・シトレ
ウスATCC11624、シクロバクテリウム・アンモ
ニアフィルムATCC15354、バシラス・サティリ
スATCC6051などが挙げられる。For example, typical examples include Corynebacterium glutamicum ATCC 13032, Corynebacterium glutamicum ATCC 21651,
Corynebacterium acetoacidophilum ATC01
3870, Corynebacterium acetoacidophilum ATCC21270, Brevibacterium lactofermentum ATCC13869, Brevibacterium
flavum ATCC 14067, Brevibacterium flavum ATCC 13826, Arthrobacterium citreus ATCC 11624, Cyclobacterium ammoniaphyllum ATCC 15354, Bacillus subtilis ATCC 6051, and the like.
上記微生物の培養は通常の条件下で行うことができる。The above microorganisms can be cultured under normal conditions.
これらの微生物の培養には、通常これらの菌が資化しう
る有機および無機の炭素源、窒素源およびビタミン、ミ
ネラルなどを適宜配合した培地を用いる。すなわち、栄
養培地の炭素源としては、たとえばグルコース、フルク
トース、シュクロース、水溶性デンプンなどの糖類、グ
リセロール、ソルビトール、マンニトールなどの糖アル
コール類、フマール酸、乳酸などの有機酸を使用するこ
とができる。炭素源の添加量は通常、培地に対して0.
1〜20%程度が好ましい、窒素源としては、たとえば
硫酸アンモニウム、塩化アンモニウムなどの無機酸のア
ンモニウム塩、フマル酸アンモニウム塩などの有機酸の
アンモニウム塩、コーンスチープリカー、酵母エキス、
カゼイン加水分解物などの天然有機窒素源などを使用す
ることができる。For culturing these microorganisms, a medium containing appropriate organic and inorganic carbon sources, nitrogen sources, vitamins, minerals, etc. that can be assimilated by these microorganisms is usually used. That is, as carbon sources for the nutrient medium, for example, sugars such as glucose, fructose, sucrose, and water-soluble starch, sugar alcohols such as glycerol, sorbitol, and mannitol, and organic acids such as fumaric acid and lactic acid can be used. . The amount of carbon source added is usually 0.
Examples of the nitrogen source, which is preferably about 1 to 20%, include ammonium salts of inorganic acids such as ammonium sulfate and ammonium chloride, ammonium salts of organic acids such as ammonium fumarate, corn steep liquor, yeast extract,
Natural organic nitrogen sources such as casein hydrolyzate can be used.
窒素源の添加量は通常、培地に対して0.1〜10%程
度が好ましい、また無機塩類としては、たとえばリン酸
カリウム、リン酸ナトリウムなどのリン酸アルカリ金属
、塩化カリウム、塩化ナトリウムなどの塩化アルカリ金
属、硫酸マグネシウム、硫酸第1鉄などの金属硫酸塩な
どを使用するのが好ましい、無機塩類の添加量は、通常
、培地に対して0.001〜1%程度が好適である。微
生物の培養条件は、菌の種類によるがPHを通常5.0
〜9.0、好ましくは7.0〜8゜0とし、温度を通常
、20〜40℃、好ましくは30〜37℃として好気的
に20〜72時間培養するのが通常である。The amount of nitrogen source added is usually preferably about 0.1 to 10% based on the medium. Examples of inorganic salts include alkali metal phosphates such as potassium phosphate and sodium phosphate, potassium chloride, and sodium chloride. It is preferable to use metal sulfates such as alkali metal chloride, magnesium sulfate, ferrous sulfate, etc., and the amount of inorganic salts added is usually about 0.001 to 1% based on the medium. The culture conditions for microorganisms depend on the type of bacteria, but the pH is usually 5.0.
-9.0°C, preferably 7.0-8°C, and the temperature is usually 20-40°C, preferably 30-37°C, and the culture is usually carried out aerobically for 20-72 hours.
本発明の反応においては、これらの微生物の培養物、菌
体またはその処理物を用いる。好ましくは菌体懸濁液ま
たは菌体処理物を用いる。In the reaction of the present invention, cultures, cells, or processed products of these microorganisms are used. Preferably, a bacterial cell suspension or a bacterial cell treatment product is used.
ここでいう菌体懸濁液とは、培養して得られた菌体を遠
心分離または濾過などにより取得したもので、菌体処理
物とは、培養して得られた菌体を超音波処理したものや
、たとえば公知の方法によりアクリルアミドゲル担体な
どに固定化したもの、洗浄菌体、凍結乾燥菌体、菌体抽
出物などが挙げられる。The bacterial cell suspension referred to here refers to the bacterial cells obtained by culturing them by centrifugation or filtration, and the treated bacterial cell material refers to the bacterial cells obtained by culturing them by ultrasonication. Examples include those immobilized on an acrylamide gel carrier by a known method, washed bacterial cells, freeze-dried bacterial cells, and bacterial cell extracts.
反応基質であるベンジル乳酸の反応液中での濃度は、通
常0.1〜5%程度用いることができる。添加方法に関
しては一括あるいは分割添加のどちらでもよい。The concentration of benzyl lactic acid, which is a reaction substrate, in the reaction solution can generally be about 0.1 to 5%. Regarding the addition method, it may be added all at once or in parts.
反応温度は、通常20〜40℃、好ましくは25〜35
℃である0反応液のPHは、通常5〜11.0、好まし
くは7.5〜9.0に保たれる。The reaction temperature is usually 20-40°C, preferably 25-35°C.
The pH of the reaction solution is usually maintained at 5 to 11.0, preferably 7.5 to 9.0.
反応時間は反応温度によって異なるが、通常30℃で3
0〜90時間である。The reaction time varies depending on the reaction temperature, but is usually 30℃ at 30℃.
0 to 90 hours.
反応方式としては、培養終了液に基質を添加し、好気的
に振とうする方法と、菌体懸濁液あるいは菌体処理物に
基質を添加し、好気的に振とうする方法があり、どちら
も採用可能であるが後者の方が良好な結果を与える。There are two reaction methods: one is to add a substrate to the cultured solution and shake aerobically, and the other is to add a substrate to a bacterial cell suspension or treated bacterial cell material and shake aerobically. , both can be adopted, but the latter gives better results.
また、反応時間の短縮あるいはL−ホモフェニルアラニ
ンの蓄積量の増加をはかるために界面活性剤および補酵
素などの存在下に実施するのが好ましい、ここで界面活
性剤としては、たとえば、ポリエチレングリコール・p
−イソオクチルフェニルエーテル、臭化セチルトリメチ
ルアンモニウムなどを用いることができ、その使用量は
、反応液に対して0.0001〜1%程度とするのが好
ましい、また、補酵素としては、たとえば、ピリドキサ
ールリン酸を挙げることができ、その使用量は反応液に
対して1〜1,000μM程度の濃度で用いるのが好ま
しい。In addition, in order to shorten the reaction time or increase the amount of L-homophenylalanine accumulated, it is preferable to carry out the reaction in the presence of a surfactant and a coenzyme. Examples of the surfactant include polyethylene glycol, p
-Isooctyl phenyl ether, cetyltrimethylammonium bromide, etc. can be used, and the amount used is preferably about 0.0001 to 1% based on the reaction solution.As the coenzyme, for example, Pyridoxal phosphoric acid can be mentioned, and it is preferable to use the amount thereof in a concentration of about 1 to 1,000 μM based on the reaction solution.
本発明の反応はアミノ基供与体としてL−グルタミン酸
存在下で行うことにより、さらに効率よく反応が進行す
る。L−グルタミン酸を添加する場合の添加量は、培地
に対して0.1〜20%が好・ましい。The reaction of the present invention proceeds more efficiently when carried out in the presence of L-glutamic acid as an amino group donor. When L-glutamic acid is added, the amount added is preferably 0.1 to 20% based on the medium.
かくして、本発明の反応により、ベンジル乳酸からL−
ホモフェニルアラニンが生成する。Thus, by the reaction of the present invention, L-
Homophenylalanine is produced.
かくして生成したL−ホモフェニルアラニンを反応液か
ら単離するには、一般的な分離精製方法を用いればよい
、たとえば、L−ホモフェニルアラニンはそれ自体水に
対してほとんど不溶であるため、酸またはアルカリを加
えL−ホモフェニルアラニンを溶解させ、不純物を濾過
、遠心分離などの常法で反応液から取り除いたのち、枦
液を中和してL−ホモフェニルアラニンを単離採取する
ことができる。To isolate the L-homophenylalanine thus produced from the reaction solution, a general separation and purification method may be used. For example, since L-homophenylalanine itself is almost insoluble in water, acid or alkali is added to dissolve L-homophenylalanine, impurities are removed from the reaction solution by a conventional method such as filtration or centrifugation, and then the L-homophenylalanine can be isolated and collected by neutralizing the solution.
また、本発明において(R8)−ベンジル乳酸を原料と
して使用する場合、基質となるベンジル乳酸の8体のみ
が、L−ホモフェニルアラニンに変換されるため、反応
液中にL−ホモフェニルアラニンが蓄積すると同時に(
R)−ベンジル乳酸も得ることができる。In addition, when (R8)-benzyl lactic acid is used as a raw material in the present invention, only 8 forms of benzyl lactic acid as a substrate are converted to L-homophenylalanine, so if L-homophenylalanine accumulates in the reaction solution, at the same time(
R)-benzyl lactic acid can also be obtained.
〈実施例〉
以下、実施例を挙げて、本発明をさらに具体的に説明す
る。<Examples> Hereinafter, the present invention will be explained in more detail with reference to Examples.
なお、実施例中、L−ホモフェニルアラニンの生成量お
よび光学純度は、高速液体クロマトグラフィー(HPL
C)を用い下記の条件で分析した(光学純度分析はJo
urnal of Chromatograpby、
202 (1980)375−379゜記載の方法に
よる)。In the Examples, the production amount and optical purity of L-homophenylalanine were determined by high performance liquid chromatography (HPL).
C) under the following conditions (optical purity analysis was carried out by Jo
urnal of chromatography,
202 (1980) 375-379)).
L−ホモフェニルアラミンの生成量
カラム 二 カプセルパックCps(資生堂)液出液
:0.01%H3PO4/アセトニトリル=83/17
流量:
検 出 :
1、5 ml / llin
UV214nm
L−ホモフェニルアラミンの光学純度
カラム : A−3020DS (MMC)液出液
:0.05%H3PO4/アセトニトリル=65/35
流量: 1.Oml /l1lin
誘導化試薬: 2.3.4.6− tetra−0−a
cct71−β−gl+cop7ranos711so
thioc7a++ate(GITC’)
検 出 : UV254nn+また、実施例中
、収率は反応基質に対する生成したL−ホモフェニルア
ラニンのモル%で表わす。L-homophenylalamine production amount column 2 Capsule pack Cps (Shiseido) liquid extract
: 0.01% H3PO4/acetonitrile = 83/17 Flow rate: Detection: 1.5 ml/llin UV214nm L-homophenylalamine optical purity column: A-3020DS (MMC) eluate
:0.05%H3PO4/acetonitrile=65/35 Flow rate: 1. Oml/l1lin derivatization reagent: 2.3.4.6-tetra-0-a
cct71-β-gl+cop7ranos711so
thioc7a++ate (GITC') Detection: UV254nn+ In the examples, the yield is expressed as mol% of L-homophenylalanine produced relative to the reaction substrate.
実施例1
グルコース2%、ポリペプトン1%、ポリペプトン81
.5%、イーストエキス0.15%、リン酸二水素カリ
ウム0.4%からなる培地50m1(pH7,5)を5
0m1の振とうフラスコに入れ120℃で10分間滅菌
した。この培地にコリネバクテリウム・グルタミカムA
TCC13032、ATCC21651、コリネバクテ
リウム・アセトアシドフィルムATCC13870、A
TCC21270、ブレビバクテリウム・ラクトファー
メンタムATCC13869、ブレビバクテリウム・デ
ィバアリカタムATCC14020、アースロバフタ−
・シトレウムATCC11624、シクロバクテリウム
・アンモニアフィルミATCC15354、バシラス・
サティリスATCC6051を各々1白金耳後種後、3
0℃で72時間振盪培養しな、培養後、培養液から遠心
分離により集菌した菌体をイオン交換水で1回洗浄後、
凍結保存しな。Example 1 Glucose 2%, Polypeptone 1%, Polypeptone 81
.. 5% yeast extract, 0.15% yeast extract, and 0.4% potassium dihydrogen phosphate (pH 7.5).
The mixture was placed in a 0ml shaking flask and sterilized at 120°C for 10 minutes. Corynebacterium glutamicum A was added to this medium.
TCC13032, ATCC21651, Corynebacterium acetoacidophilum ATCC13870, A
TCC21270, Brevibacterium lactofermentum ATCC13869, Brevibacterium divalicatum ATCC14020, Arthrobacterium
・Citreum ATCC11624, Cyclobacterium ammoniafilmi ATCC15354, Bacillus・
Satiris ATCC 6051, 1 platinum postspecies, 3 each
After culturing with shaking at 0°C for 72 hours, the bacterial cells collected from the culture solution by centrifugation were washed once with ion-exchanged water.
Do not store frozen.
(R3)−ベンジル乳酸1.5%、L−グルタミン酸ナ
トリウム3%、ピリドキサールリン酸50μM、ポリエ
チレングリコール・p−インオクチルフェニルエーテル
1 v / v%の0.1 Mリン酸バッフy−(pH
7,5)溶液50m1に得られた凍結保存菌体を十分に
懸濁した。この懸濁液を30℃で100時間反応させた
のちのし−ホモフェニルアラニンの生成量は表1のとお
りであった。(R3)-benzyl lactic acid 1.5%, sodium L-glutamate 3%, pyridoxal phosphate 50 μM, polyethylene glycol p-yne octylphenyl ether 1 v/v% in 0.1 M phosphate buffer y-(pH
7,5) The obtained cryopreserved bacterial cells were sufficiently suspended in 50 ml of solution. Table 1 shows the amount of homophenylalanine produced after reacting this suspension at 30° C. for 100 hours.
なお、生成したL−ホモフェニルアラニンの光学純度は
、全ての場合においてほぼ100%であった。Note that the optical purity of the produced L-homophenylalanine was approximately 100% in all cases.
表
実地例2
グルコース40 t 、 D L−乳酸20.g、!酸
アンモニウム20g、リン酸二水素カリウム2ぎ、塩化
ナトリウムIg、尿素5g、硫酸第1鉄7水和物を20
■、硫酸マンガン20■、ビオチン50a含有する2I
lの液体培地を51ジャーファーメンタ−に入れ、11
5℃で20分間減菌した。この5J!のジャーファーメ
ンタ−にあらかじめ同培地100 ml中、30℃で7
2時間振どう培養したコリネバクテリウム・グルタミカ
ムATCC13032を接種し、30℃で48時間通気
撹拌培養を行った。培養後、培養液から遠心分離によっ
て集菌した菌体をイオン交換水で1回洗浄し、2等分し
て凍結保存した。Surface practical example 2 Glucose 40t, D L-lactic acid 20. G,! 20g of ammonium acid, 2g of potassium dihydrogen phosphate, Ig of sodium chloride, 5g of urea, 20g of ferrous sulfate heptahydrate.
■, 2I containing manganese sulfate 20■, biotin 50a
Pour 1 liter of liquid culture medium into a 51 jar fermenter,
Sterilization was performed at 5°C for 20 minutes. This 5J! In advance, add 100 ml of the same medium to a jar fermenter at 30℃ for 7 days.
Corynebacterium glutamicum ATCC 13032, which had been cultured with shaking for 2 hours, was inoculated and cultured with aeration at 30° C. for 48 hours. After culturing, the bacterial cells collected from the culture solution by centrifugation were washed once with ion-exchanged water, divided into two equal parts, and stored frozen.
(R8)−ベンジル乳酸20Kを50μMのリン酸バッ
フザー(pH9,0)141に溶解し、水酸化ナトリウ
ム水溶液でp H9,0にFlfiした。(R8)-Benzyl lactic acid 20K was dissolved in 50 μM phosphate buffer (pH 9,0) 141, and Flfid to pH 9,0 with an aqueous sodium hydroxide solution.
この基質溶液に得られた凍結保存菌体の半分を十分に懸
濁後、30℃で24時間、51のジャ−ファメンター中
で撹拌したのち、この反応液にL−グルタミン酸ナトリ
ウム20g、ピリドキサールリン酸50μM、ポリエチ
レングリコール・p−イソオクチルフェニルエーテル1
v/■%の水溶液11を加えた。塩酸でpHを7゜5に
調整し、さらに実施例2で得られた菌体の残り半分を十
分に懸濁後、30℃で72時間撹拌した0反応後、遠心
分離により固型物を分離後、得られた固型物を0. I
N塩酸21で十分に洗浄した。さらに、遠心分離によ
り菌体を分離後、溶液側を全濃縮し、過剰の塩酸を留去
した。After fully suspending half of the cryopreserved cells obtained in this substrate solution, the mixture was stirred at 30°C for 24 hours in a 51 jar fermenter. Acid 50μM, polyethylene glycol p-isooctylphenyl ether 1
V/■% aqueous solution 11 was added. After adjusting the pH to 7°5 with hydrochloric acid and thoroughly suspending the remaining half of the bacterial cells obtained in Example 2, the mixture was stirred at 30°C for 72 hours. After a zero reaction, solid matter was separated by centrifugation. After that, the obtained solid material was reduced to 0. I
It was thoroughly washed with 21 liters of N-hydrochloric acid. Furthermore, after separating the bacterial cells by centrifugation, the solution side was completely concentrated and excess hydrochloric acid was distilled off.
残渣を1jの水に溶解し、水酸化ナトリウム水溶液でp
H5〜6に調整した。析出物を濾過後、水洗して、40
℃で減圧乾燥することによりL−ホモフェニルアラニン
7.8gを得た(単離収率78%、光学純度99%)。Dissolve the residue in 1j of water and dilute with aqueous sodium hydroxide solution.
Adjusted to H5-6. After filtering the precipitate, it was washed with water and
By drying under reduced pressure at °C, 7.8 g of L-homophenylalanine was obtained (isolated yield 78%, optical purity 99%).
〈発明の効果〉
本発明によれば、ベンジル乳酸からL−ホモフェニルア
ラニンを高収率かつ高純度で効率よく得ることができる
。また、反応基質濃度を高くすることができるので、反
応時間を短縮できかつ収率も向上できる。さらに、高価
な光学分割剤が不要であり、安価に製造することができ
る。<Effects of the Invention> According to the present invention, L-homophenylalanine can be efficiently obtained in high yield and purity from benzyl lactic acid. Furthermore, since the concentration of the reaction substrate can be increased, the reaction time can be shortened and the yield can also be improved. Furthermore, there is no need for an expensive optical resolution agent, and it can be manufactured at low cost.
特許出願大東し株式会社Patent application Daitoshi Co., Ltd.
Claims (1)
力を有しかつコリネバクテリウム(Corynebac
terium)属、ブレビバクテリウム(Brevib
acterium)属、バシラス(Bacillus)
属、ミクロバクテリウム(Microbacteriu
m)属またはアースロバクター(Arthrobact
er)属に属する微生物より選ばれた少なくとも1種の
微生物の培養物、菌体またはその処理物をベンジル乳酸
に作用させてL−ホモフェニルアラニンを生成蓄積せし
め、反応液からL−ホモフェニルアラニンを単離採取す
ることを特徴とするL−ホモフェニルアラニンの製法。Corynebacterium has the ability to convert benzyl lactic acid to L-homophenylalanine and
terium), Brevibacterium (Brevib)
genus acterium, Bacillus
Genus, Microbacterium
m) Genus or Arthrobacter
er) A culture, bacterial cells, or a processed product thereof of at least one type of microorganism selected from the microorganisms belonging to the genus genus is allowed to act on benzyl lactic acid to produce and accumulate L-homophenylalanine, and L-homophenylalanine is isolated from the reaction solution. 1. A method for producing L-homophenylalanine, which is characterized by separate collection.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24883789A JPH03112491A (en) | 1989-09-25 | 1989-09-25 | Production of l-homophenylalanine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24883789A JPH03112491A (en) | 1989-09-25 | 1989-09-25 | Production of l-homophenylalanine |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH03112491A true JPH03112491A (en) | 1991-05-14 |
Family
ID=17184158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP24883789A Pending JPH03112491A (en) | 1989-09-25 | 1989-09-25 | Production of l-homophenylalanine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH03112491A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6146859A (en) * | 1999-08-27 | 2000-11-14 | Academia Sinica | Facile synthesis of L-homophenylalanine by equilibrium shift enzymatic reaction using engineered tyrosine aminotransferase |
-
1989
- 1989-09-25 JP JP24883789A patent/JPH03112491A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6146859A (en) * | 1999-08-27 | 2000-11-14 | Academia Sinica | Facile synthesis of L-homophenylalanine by equilibrium shift enzymatic reaction using engineered tyrosine aminotransferase |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0249188B1 (en) | Process for the production of L-2-amino-4-(hydroxymethyl-phosphinyl)-butyric acid | |
Tsugawa et al. | Production of l-Glutamic Acid from dl-Hydantoin-5-propionic Acid by Microoganisms: Part I. Screening of l-Glutamic Acid-Producing Microorganisms and Some Optimal Conditions for Production of l-Glutamic Acid | |
JPS5816872B2 (en) | Corynebacterium glutamicum mutant strain | |
GB2042531A (en) | Process for preparing D-???-amino acids | |
JPS62289A (en) | Enzymatic production of l-alpha-amino acid from alpha-ketoic acid | |
US5238827A (en) | Process for preparing glycine from glycinonitrile | |
US3767528A (en) | Process for the manufacture of 3,4-disubstituted phenyl-l-alanines | |
JPH10248588A (en) | Production of l-serine by fermentation | |
US5116743A (en) | L-alanine production with two microorganisms having fumarase inactivity in a single reaction tank | |
US3734829A (en) | Fermentative preparation of l-arginine | |
JPH04365491A (en) | Production of 4-halo-3-hydroxybutylamide | |
JPH03112491A (en) | Production of l-homophenylalanine | |
JPH03112490A (en) | Production of l-homophenylalanine | |
GB2113691A (en) | Production of l-threonine | |
JPH01320991A (en) | Production of d-homophenylalanines | |
US5149651A (en) | Process for culturing microorganisms of the genus pseudomonas and process for producing l-alanine using said microorganisms | |
JPH0148758B2 (en) | ||
EP0295622B1 (en) | Process for producing l-tryptophan | |
JPH0438398B2 (en) | ||
JP2899071B2 (en) | Method for producing L-α-alanine | |
JPH0253494A (en) | Production of d-glutamic acid | |
JPS6258710B2 (en) | ||
JPH01257486A (en) | Production of l-arginine by fermentation method | |
JPH0449997B2 (en) | ||
JPH0158957B2 (en) |